ReviewCancers2026
Beyond Overdiagnosis: Evaluating the Drivers of Increasing Thyroid Cancer Incidence in the Era of Obesity, Environmental Exposure, and Advanced Diagnostics.
Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global incidence of thyroid cancer (TC) has increased significantly in recent decades. Traditionally, this trend has been attributed to overdiagnosis resulting from the widespread use of imaging and improved diagnostic techniques, but increasing evidence suggests that current epidemiological patterns may not be fully explained by diagnostic factors alone. Most importantly, increasing rates of larger and more advanced tumors have been reported in several populations. This narrative review discusses the evidence on possible drivers of rising TC incidence: obesity and metabolic dysfunction, environmental exposures such as air pollution, and endocrine-disrupting chemicals (EDCs) and ionizing radiation, as well as molecular and genetic mechanisms involved in thyroid carcinogenesis. The role of advances in diagnostics and their contribution to overdiagnosis are also discussed. Current available data support a multifactorial model with better detection coupled with changes in environmental, metabolic and biological risk factors. A better understanding of the relative contribution and interaction of these determinants may help refine diagnostic strategies, reduce unnecessary interventions, and improve the prevention and management of TC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.